����ֱ����Ƶ

The fourth event of the LSHTM-Charité Global Health Lecture Series will focus on Antimicrobial resistance (AMR) in light of the current COVID-19 pandemic, exploring how a One Health approach can be leveraged to stem the rise of drug resistance infections.  

, UK Special Envoy on Antimicrobial Resistance, , Director of the Institute for Hygiene and Environmental Medicine at the Charité – Universitätsmedizin Berlin and , Head of South Asia at the Center for Disease Dynamics, Economics & Policy (CDDEP) will speak at the event, providing insights into how the current pandemic is impacting on AMR, exploring the ‘One Health’ approach to tackling antimicrobial resistance, and discussing policy tensions and implementation challenges that exist. , Director-General for Life Sciences at the German Federal Ministry of Education and Research, will chair the event and will provide reflections on the policy context in Germany.

Key questions guiding the event will be:

• What impact has COVID-19 had on antimicrobial resistance?
• What opportunities may arise from the pandemic that could help tackle AMR in future?
• How might a “One Health” approach be leveraged to build back better?  
• What advances in research and policy including global level governance are needed to address current gaps

About the speakers

Prof Veronika von Messling (Chair)

Prof Veronika von Messling is Director-General for Life Sciences at the German Federal Ministry of Education and Research. She obtained her veterinary degree and her doctorate degree in veterinary virology from the Veterinary School Hannover, Germany. After postdoctoral training at Mayo Clinic in Rochester, MN, she was Assistant Professor at INRS-Institut Armand-Frappier in Laval, QC, and then Associate Professor at Duke-NUS Medical School, Singapore, before becoming Director of the Veterinary Division at Paul-Ehrlich-Institute, the German Federal Institute of Vaccines and Biomedicines, in Langen, Germany. Her expertise lies in the development of novel prophylactic and therapeutic strategies against infectious diseases.

was appointed as the UK Government’s Special Envoy on AMR in 2019. She is also the 40th Master of Trinity College, Cambridge University. She joined the College after a distinguished career as a clinical academic and public servant. Dame Sally graduated from Manchester Medical School in 1972 and became a Consultant Haematologist specialising in sickle cell disease. In 1997 she was appointed as Honorary Professor of Haemoglobinopathies at Imperial College. Dame Sally was the Chief Medical Officer for England and Senior Medical Advisor to the UK Government from 2011-2019. She authorised 11 independent annual reports and 3 special reports: Medical Cannabis, Screen Times for Children and Obesity in Childhood. She has become a leading figure in global health including serving as a member of the World Health Organisation (WHO) Executive Board 2014-2016 and as co-convener of the United Nations Inter-Agency Co-ordination Group (IACG) on Antimicrobial Resistance (AMR) reporting in 2019. She has championed the need to address AMR across all sections: human and animal health, agriculture and environment within the UN family and globally. In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research having received her DBE in 2009. She was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, USA in 2015. She has been awarded more than 30 honorary doctorate degrees.

is Head of the Institute of Hygiene and Environmental Medicine at the Charite-Universitätsmedizin Berlin. Prof Gastmeier is an expert on surveillance of nosocomial infections and antimicrobial resistance and has published more than 400 scientific papers and review articles in this field. In 2003, she was presented with the top award of the German Society for Hygiene and Microbiology (DGHM), and was honoured with the Hygiene Prize of the Rudolf Schülke Foundation in 2007. During this time, she headed up the General and Hospital Hygiene Specialist Group at DGHM, and she was Vice-President of DGHM from 2006 to 2010. In 2007, she was appointed to a W3 professorship in hygiene at the Charité, and has been Director of the Institute of Hygiene and Environmental Medicine at Charité since early 2008, leading the National Reference Centre for Surveillance of Nosocomial Infections. She has also been running the national “Clean Hands Campaign” since 2008. Over the past 10 years, Petra Gastmeier has worked in multiple Robert Koch Institute (RKI) committees, is a Member of the Supervisory Board of the Helmholtz Centre for Infection Research (HZI), has contributed to many working groups of the European Centre for Disease Prevention and Control (ECDC), and was involved in various WHO advisory boards. In 2013, she was the Local Congress President of the European Congress of Clinical Microbiology and Infectious Diseases, with over 10,000 participants. In 2015, Prof Gastmeier received the Robert Koch award for Hospital Epidemiology and Infection Prevention.

 is Head of South Asia at the Center for Disease Dynamics, Economics & Policy (CDDEP) and an Adjunct Professor at Amity Institute of Public Health, Amity University, India. She is a medical doctor with specialization in Community Medicine and Infectious diseases. Jyoti has worked with government health programs for almost two decades and her research interests include antimicrobial resistance (AMR), vaccines & infectious diseases and health systems. As the South Asia lead for the Global Antibiotic Research Partnership (GARP) project, she supported the development of in-country policy analysis capacity to address AMR in low and middle income countries (LMIC) in Asia. Jyoti serves as a Board member for SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium), a think tank of experts, established by the Wellcome Trust to share expertise and take action to tackle the gaps in drug-resistant infections surveillance and epidemiology. In her current role , she has worked with World Health Organisation (WHO) on several projects such as undertake country case studies and develop global guidance for implementing National Action Plans for AMR and translating them from paper to the field by integrating AMR sensitive and AMR specific approaches within the existing health programs.

Please note that the time listed is British Summer Time (BST).                   

The LSHTM-Charité Global Health Lecture Series is supported by the Bill & Melinda Gates Foundation and this event on Pandemic Preparedness is also supported by the Wellcome Trust.